| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10297400 | Comprehensive Psychiatry | 2014 | 7 Pages |
Abstract
A correlation between IGF-1 and MS may significantly influence future therapeutic strategies for MS. In order to determine the role of IGF-1 in schizophrenia, comprehensive longitudinal studies with first-episode drug-naive patients are needed.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Aysegul Demirel, Omer Faruk Demirel, Murat Emül, Alaattin Duran, Mufit UÄur,